http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101312422-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-255 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-34 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05 |
filingDate | 2005-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2013-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101312422-B1 |
titleOfInvention | Anti-radical |
abstract | (1)n n n Compound of (1);n n n Formula (2)n n n The compound of (2); Andn n n Formula (3) Selected hindered nitroxy, hydroxylamine and hydroxylamine salt compounds, such as the compound of (3), exhibit marked anti-inflammatory action:n n n In the above formulas (1), (2) and (3),n n n G 1 is hydrogen; C 1 -C 22 alkyl; C 1 -C 22 alkylthio; C 2 -C 22 alkylthioalkyl; C 5 -C 7 cycloalkyl; Phenyl; C 7 -C 9 phenylalkyl; Or SO 3 M; G 2 is C 1 -C 22 alkyl; C 5 -C 7 cycloalkyl; Phenyl; Or C 7 -C 9 phenylalkyl; E is oxyl or hydroxyl; V is -O-; Or -NH-; ; a is 0 or 1 or 2; b, c and d and g are each independently 0 or 1; e is an integer from 1 to 4; f, m, n and p are each independently an integer from 1 to 3; q is 0 or an integer from 1 to 3; Q, T and G 3 are as defined in claim 1; G 4 and G 5 are independently of each other hydrogen; Or C 1 -C 22 alkyl.n n n Anti-inflammatory action, steric hindrance nitroxyl, hydroxylamine, hydroxylamine, pharmaceutical composition, allergy, skin damage |
priorityDate | 2004-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.